中国全科医学 ›› 2021, Vol. 24 ›› Issue (34): 4409-4414.DOI: 10.12114/j.issn.1007-9572.2021.00.284

所属专题: 跌倒最新文章合集 老年问题最新文章合集

• 专题研究 • 上一篇    下一篇

老年人跌倒相关药物管理的研究进展

黄雅南1,杨小璇1,陈孝1,元刚2*   

  1. 1.510080广东省广州市,中山大学附属第一医院药学部
    2.510080广东省广州市,中山大学附属第一医院老年病科
    *通信作者:元刚,副主任医师,硕士生导师;E-mail:yuangang@mail.sysu.edu.cn
  • 出版日期:2021-12-05 发布日期:2021-12-05

Recent Advances in Pharmaceutical Management of Falls in Older People 

HUANG Ya'nan1,YANG Xiaoxuan1,CHEN Xiao1,YUAN Gang2*   

  1. 1.Department of Pharmacy,the First Affiliated Hospital,Sun Yat-Sen University,Guangzhou 510080,China
    2.Department of Geriatrics,the First Affiliated Hospital,Sun Yat-Sen University,Guangzhou 510080,China
    *Corresponding author:YUAN Gang,Associate chief physician,Master supervisor;E-mail:yuangang@mail.sysu.edu.cn
  • Published:2021-12-05 Online:2021-12-05

摘要: 老年人群跌倒发生率较高,跌倒是老年人发生伤残、失能和死亡的重要原因。开展跌倒风险评估和管理,对降低跌倒发生率、减少伤害严重程度具有重要意义。药物因素是跌倒风险评估的重要组成部分,药物干预则是预防跌倒管理中必不可少的环节,但跌倒的药物干预在处理决策和管理上尚无统一标准,受重视程度不足。近年来有学者针对老年人跌倒药物干预的必要性和可行性进行了相关研究,现就药物干预方式和手段进行综述,以期对药物干预的开展提供思路和借鉴。

关键词: 意外跌倒, 老年人, 药物干预, 增加跌倒风险药物, 多重用药, 维生素D

Abstract: In older people,the incidence of falls is high,which are an important cause of injury,disability and death. So assessing the risk of falls and managing falls are essential to reduce falls incidence and the severity of injuries. Pharmaceutical factors are a key component of risk assessment of falls. And pharmaceutical interventions are vital in the management of falls,but there are no uniform criteria for how to make decision to deliver and manage pharmaceutical interventions for falls,which may be due to inadequate importance attached to these aspects. Given that some scholars have carried out relevant research on the necessity and feasibility of delivering pharmaceutical interventions for falls,we reviewed the latest advances in pharmaceutical interventions for falls in older adults,aiming at providing useful ideas for furthering the development of pharmaceutical interventions.

Key words: Accidental falls, Aged, Pharmaceutical intervention, Fall risk-increasing drugs, Polypharmacy, Vitamin D